期刊
MOLECULAR IMAGING
卷 16, 期 -, 页码 -出版社
SAGE PUBLICATIONS INC
DOI: 10.1177/1536012116685941
关键词
molecular imaging; apoptosis; early response; F-18-ML-10; PET
资金
- US National Institutes of Health [U01 CA140230]
- Department of Energy [DE SC0008833]
- NCI Cancer Center Support Grant [P30CA047904]
- U.S. Department of Energy (DOE) [DE-SC0008833] Funding Source: U.S. Department of Energy (DOE)
Purpose: We investigated 2-(5-fluoro-pentyl)-2-methyl-malonic acid (F-18-ML-10) positron emission tomography (PET) imaging of apoptosis posttherapy to determine optimal timing for predicting chemotherapy response in a mouse head/neck xenograft cancer model. Procedures: BALB/c nude mice (4-8 weeks old) were implanted with UM-SCC-22B tumors. The treatment group received 2 doses of doxorubicin (10 mg/kg, days 0, 2). Small animal F-18-ML-10 PET/computed tomography was performed before and on days 1, 3, and 7 postchemotherapy. Using regions of interest around tumors, F-18-ML-10 uptake change was measured as %ID/g and uptake relative to liver. Terminal Uridine Nick-End Labeling (TUNEL) immunohistochemistry assay was performed using tumor samples of baseline and on days 1, 3, and 7 posttreatment. Results: Treated mice demonstrated increased F-18-ML-10 uptake compared to baseline and controls, and 10 of 13 mice showed tumor volume decreases. All control mice showed tumor volume increases. Tumor-to-liver (T/L) ratios from the control group mice did not show significant change from baseline (P > .05); however, T/L ratios of the treatment group showed significant F-18-ML-10 uptake differences from baseline compared to days 3 and 7 posttreatment (P < .05), but no significant difference at 1 day posttreatment. Conclusion: 2-(5-Fluoro-pentyl)-2-methyl-malonic acid PET imaging has the potential for early assessment of treatment-induced apoptosis. Timing and image analysis strategies may require optimization, depending on the type of tumor and cancer treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据